SIGHT SCIENCES INC Share Price Today: Live Updates & Key Insights

SIGHT SCIENCES INC share price today is $3.465, up -2.8%. The stock opened at $3.54 against the previous close of $3.57, with an intraday high of $3.54 and low of $3.41.

SIGHT SCIENCES INC Share Price Chart

SIGHT SCIENCES INC

us-stock
To Invest in {{usstockname}}
us-stock

SIGHT SCIENCES INC Share Price Performance

$3.465 -0.028(-2.8%) SGHT at 23 Mar 2026 03:11 PM Medical Devices
Lowest Today 3.41
Highest Today 3.54
Today’s Open 3.54
Prev. Close 3.57
52 Week High 9.24
52 Week Low 2.03
Day’s Range: Low 3.41 High 3.54
52-Week Range: Low 2.03 High 9.24
1 day return -
1 Week return -7.73
1 month return -35.44
3 month return -59.05
6 month return -3.08
1 year return +12.15
3 year return -61.38
5 year return -89.81
10 year return -

SIGHT SCIENCES INC Institutional Holdings

KCK Ltd 8.10

Long Focus Capital Management, LLC 6.10

BlackRock Inc 4.71

Vanguard Group Inc 3.61

Americana Partners, LLC 2.55

Vanguard Total Stock Mkt Idx Inv 1.95

iShares Russell 2000 ETF 1.86

B Group, Inc 1.70

Geode Capital Management, LLC 1.63

Pathstone Holdings LLC 1.33

State Street Corp 1.23

Apollo Management Holdings LP 0.95

Acadian Asset Management LLC 0.88

Fidelity Small Cap Index 0.76

Vanguard Institutional Extnd Mkt Idx Tr 0.66

iShares Russell 2000 Growth ETF 0.64

Northern Trust Corp 0.63

Dimensional Fund Advisors, Inc. 0.56

Walleye Trading Advisors, LLC 0.54

Charles Schwab Investment Management Inc 0.53

Morgan Stanley - Brokerage Accounts 0.51

Renaissance Technologies Corp 0.51

Millennium Management LLC 0.49

D. E. Shaw & Co LP 0.43

State St Russell Sm/Mid Cp® Indx SL Cl I 0.37

JPMorgan Chase & Co 0.37

IMC US Ultra Micro Cap 0.37

Vanguard Russell 2000 ETF 0.37

Fidelity Extended Market Index 0.31

Schwab US Small-Cap ETF™ 0.31

Invesco Dorsey Wright SmallCap Momt ETF 0.30

State St Russell Sm Cap® Indx SL Cl I 0.28

iShares Micro-Cap ETF 0.20

1290 Essex Small Cap Growth I 0.20

Schwab Small Cap Index 0.19

Pleiades Small Cap Equity A 0.18

SEI Tax-Managed Small/Mid Cap F (SIMT) 0.18

NT R2000 Index Fund - NL 0.17

Bridgeway Ultra-Small Company Market 0.17

Blackrock Extended Mkt Fund CF 0.15

SIGHT SCIENCES INC Market Status

Strong Buy: 2

Buy: 0

Hold: 6

Sell: 0

Strong Sell: 0

SIGHT SCIENCES INC Fundamentals

Market Cap 187.40 M

PB Ratio 3.011

PE Ratio 0.0

Enterprise Value 135.94 M

Total Assets 115.30 M

Volume 566453

SIGHT SCIENCES INC Company Financials

Annual Revenue FY23:82848000 82.8M, FY22:71331000 71.3M, FY21:48956000 49.0M, FY20:27640000 27.6M, FY19:23348000 23.3M

Annual Profit FY23:70078000 70.1M, FY22:58970000 59.0M, FY21:40346000 40.3M, FY20:18431000 18.4M, FY19:16804000 16.8M

Annual Net worth FY23:-61763000 -61.8M, FY22:-86242000 -86.2M, FY21:-62960000 -63.0M, FY20:-34693000 -34.7M, FY19:-25869000 -25.9M

Quarterly Revenue Q3/2025:19906000 19.9M, Q2/2025:19564000 19.6M, Q1/2025:17508000 17.5M, Q3/2024:20157000 20.2M, Q2/2024:21370000 21.4M

Quarterly Profit Q3/2025:17197000 17.2M, Q2/2025:16587000 16.6M, Q1/2025:15094000 15.1M, Q3/2024:16907000 16.9M, Q2/2024:18345000 18.3M

Quarterly Net worth Q3/2025:-8169000 -8.2M, Q2/2025:-11941000 -11.9M, Q1/2025:-14154000 -14.2M, Q3/2024:-11066000 -11.1M, Q2/2024:-12329000 -12.3M

About SIGHT SCIENCES INC & investment objective

Company Information Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Organisation Medical Devices

Employees 186

Industry Medical Devices

CEO Mr. Paul Badawi

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

SIGHT SCIENCES INC FAQs

What is the share price of SIGHT SCIENCES INC today?

The current share price of SIGHT SCIENCES INC is $3.465.

Can I buy SIGHT SCIENCES INC shares in India?

Yes, Indian investors can buy SIGHT SCIENCES INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy SIGHT SCIENCES INC shares in India?

You can easily invest in SIGHT SCIENCES INC shares from India by:

Can I buy fractional shares of SIGHT SCIENCES INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SIGHT SCIENCES INC?

SIGHT SCIENCES INC has a market cap of $187.40 M.

In which sector does SIGHT SCIENCES INC belong?

SIGHT SCIENCES INC operates in the Medical Devices sector.

What documents are required to invest in SIGHT SCIENCES INC stocks?

To invest, you typically need:

What is the PE and PB ratio of SIGHT SCIENCES INC?

The PE ratio of SIGHT SCIENCES INC is N/A and the PB ratio is 3.01.